{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:28:24Z","timestamp":1765438104231},"reference-count":42,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T00:00:00Z","timestamp":1188259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:p>Both cytotoxic T lymphocytes (CTL) and natural killer (NK) cells may play major roles in the host defense against cancer. However, their relationship against the same tumor remains to be elucidated. Among 26 human lung cancer cell lines established in our laboratory, 10 (38%) exhibited human leukocyte antigen (HLA)\u2010class I haplotype loss and three (12%) lost HLA\u2010class I expression totally by flow cytometry analysis. The two cell lines (E522L and C831L) that lost their expression of HLA\u2010class I <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> were applied for further evaluations. Genetic abnormalities of \u03b22\u2010microglobulin gene were observed in both E522L (loss of mRNA) and C831L (point mutation). Transduction of the wild\u2010type \u03b22\u2010microglobulin gene rendered them positive for HLA\u2010class I expression. The CTL were induced from autologous peripheral blood mononuclear cells or regional lymph node lymphocytes by stimulation with wild\u2010type \u03b22\u2010microglobulin transduced\u2010E522L or \u2010C831L, and they showed tumor\u2010specific cytotoxicity against wild\u2010type \u03b22\u2010microglobulin\u2010transductant, but not parental cells. In NK cell cytotoxicity, E522L showed high sensitivity to NK cells; however, C831L showed resistance despite loss of HLA\u2010class I expression. E522L expressed MHC class I chain related molecules A\/B, but C831L did not. The transduction of the MHC class I chain related molecule A gene from E522L rendered C831L positive for expression and sensitive to NK cell cytotoxicity. Reconstruction of HLA\u2010class I and MHC class I chain related molecules A expression could abrogate evasion from cellular attack by CTL and NK cells, and it may lead to a breakthrough in the development of cancer immunotherapy. (<jats:italic>Cancer Sci<\/jats:italic> 2007; 98: 1795\u20131802)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2007.00586.x","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T13:31:09Z","timestamp":1188567069000},"page":"1795-1802","source":"Crossref","is-referenced-by-count":30,"title":["Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and\/or major histocompatibility complex class I chain related molecules A\/B"],"prefix":"10.1111","volume":"98","author":[{"given":"Tetsuro","family":"Baba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hanagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Ichiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Takenoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,28]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.8.4844"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3787"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2542"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21594"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3840"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161260098"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1100"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.240"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23373"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/319675a0"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.02.007"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115289"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.2.100"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-999"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116249"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.11.4751"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI498"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.52.220"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.3.1462"},{"key":"e_1_2_7_21_2","first-page":"4948","article-title":"Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical\u2010pathological parameters","volume":"51","author":"Redondo M","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90259-3"},{"key":"e_1_2_7_23_2","first-page":"1","article-title":"Is downregulation of MHC class I antigen expression in human non\u2010small cell lung cancer associated with prolonged survival?","volume":"27","author":"Ramnath N","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.1.282"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2817::AID-IMMU2817>3.0.CO;2-M"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.7.3062"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0595"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1998.tb00480.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21163"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21303"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10906"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.09.008"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-002-0526-9"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.12.7297"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.727"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-4252"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0599"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.4.1298"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200422206"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00507.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2517"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20782"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0944"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2007.00586.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2007.00586.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:19:23Z","timestamp":1697185163000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2007.00586.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,28]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1349-7006.2007.00586.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00586.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,28]]}}}